These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8197998)
1. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Lang CC; Prasad N; McAlpine HM; Macleod C; Lipworth BJ; MacDonald TM; Struthers AD Am Heart J; 1994 Jun; 127(6):1635-6. PubMed ID: 8197998 [No Abstract] [Full Text] [Related]
2. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918 [TBL] [Abstract][Full Text] [Related]
3. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Arad M; Elazar E; Shotan A; Klein R; Rabinowitz B Cardiology; 1996; 87(1):12-7. PubMed ID: 8631038 [TBL] [Abstract][Full Text] [Related]
4. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085 [TBL] [Abstract][Full Text] [Related]
5. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969 [TBL] [Abstract][Full Text] [Related]
6. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Clarkson PB; Wheeldon NM; MacFadyen RJ; Pringle SD; MacDonald TM Circulation; 1996 Jun; 93(11):2037-42. PubMed ID: 8640980 [TBL] [Abstract][Full Text] [Related]
7. Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure. Wijbenga AA; Balk AH; Jonkman FA; Boomsma F; Simoons ML; Man in t Veld AJ Eur J Heart Fail; 1999 Mar; 1(1):51-8. PubMed ID: 10937980 [TBL] [Abstract][Full Text] [Related]
8. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Omland T; Aakvaag A; Vik-Mo H Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981 [TBL] [Abstract][Full Text] [Related]
9. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907 [TBL] [Abstract][Full Text] [Related]
10. Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis. Ishikura F; Ando Y; Park YD; Tani A; Shirai D; Matsuoka H; Miyatake K Ren Fail; 1996 Mar; 18(2):261-70. PubMed ID: 8723364 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of symptomless left ventricular dysfunction. Barnett DB Lancet; 1993 May; 341(8853):1124-5. PubMed ID: 8097808 [No Abstract] [Full Text] [Related]
12. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996 [TBL] [Abstract][Full Text] [Related]
13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508 [TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptides in detection of heart failure. Dickstein K Lancet; 1998 Jan; 351(9095):4. PubMed ID: 9433417 [No Abstract] [Full Text] [Related]
16. Diagnosis of symptomless left ventricular dysfunction. Tan LB; Hall A Lancet; 1993 Jul; 342(8863):116-7. PubMed ID: 8100883 [No Abstract] [Full Text] [Related]
17. Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Nakamura M; Niinuma H; Chiba M; Ueshima K; Arakawa N; Yagi Y; Kawazoe K; Hiramori K Am J Cardiol; 1997 Apr; 79(7):966-70. PubMed ID: 9104915 [TBL] [Abstract][Full Text] [Related]
18. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Morita E; Yasue H; Yoshimura M; Ogawa H; Jougasaki M; Matsumura T; Mukoyama M; Nakao K Circulation; 1993 Jul; 88(1):82-91. PubMed ID: 8319360 [TBL] [Abstract][Full Text] [Related]
19. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Maeda K; Tsutamoto T; Wada A; Hisanaga T; Kinoshita M Am Heart J; 1998 May; 135(5 Pt 1):825-32. PubMed ID: 9588412 [TBL] [Abstract][Full Text] [Related]
20. Influence of candoxatril on plasma brain natriuretic peptide in heart failure. Lang CC; Motwani J; Coutie WJ; Struthers AD Lancet; 1991 Jul; 338(8761):255. PubMed ID: 1676808 [No Abstract] [Full Text] [Related] [Next] [New Search]